Category: Press Release - Page 100 - Psychedelic Alpha

Read more about the article ATMA Journey Centers Offer Regulated Health Care Professionals a Means to Incorporate Psychedelic-Assisted Psychotherapy Into Their Practice

ATMA Journey Centers Offer Regulated Health Care Professionals a Means to Incorporate Psychedelic-Assisted Psychotherapy Into Their Practice

Post published:September 23, 2021
Post category:Press Release

Read more about the article MINDCURE Signs Exclusive Digital Clinical Data Licensing Agreement with ATMA Journey Centers

MINDCURE Signs Exclusive Digital Clinical Data Licensing Agreement with ATMA Journey Centers

Post published:September 23, 2021
Post category:Press Release

Read more about the article Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data

Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data

Post published:September 22, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in Eating Disorders

Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in Eating Disorders

Post published:September 22, 2021
Post category:Press Release

Read more about the article Bright Minds Biosciences Provides Scientific Update

Bright Minds Biosciences Provides Scientific Update

Post published:September 22, 2021
Post category:Press Release

Read more about the article Mycrodose Therapeutics Successfully Completes Oversubscribed Private Placement to Expand Existing Patent Portfolio of Breakthrough Advanced Drug Delivery Technologies

Mycrodose Therapeutics Successfully Completes Oversubscribed Private Placement to Expand Existing Patent Portfolio of Breakthrough Advanced Drug Delivery Technologies

Post published:September 21, 2021
Post category:Press Release

Read more about the article Psyched Wellness Initiates a Clinical Sleep Study on Humans for a Structure/Function Claim For AME-1

Psyched Wellness Initiates a Clinical Sleep Study on Humans for a Structure/Function Claim For AME-1

Post published:September 21, 2021
Post category:Press Release

Read more about the article Small Pharma Successfully Completes Phase I Clinical Trial of DMT in Combination with Supportive Psychotherapy

Small Pharma Successfully Completes Phase I Clinical Trial of DMT in Combination with Supportive Psychotherapy

Post published:September 21, 2021
Post category:Press Release

Read more about the article DemeRx Doses First Subject in Phase 1/2a Study of DMX-1002 (Ibogaine) in Opioid Use Disorder

DemeRx Doses First Subject in Phase 1/2a Study of DMX-1002 (Ibogaine) in Opioid Use Disorder

Post published:September 21, 2021
Post category:Press Release

Mindset Pharma Announces Further Preclinical Results Demonstrating Strong Efficacy and Improved Safety Profile for its 5-MeO-DMT-Inspired Drug Candidate, MSP-4018

Post published:September 20, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.